{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:22:12Z","timestamp":1782512532328,"version":"3.54.5"},"reference-count":97,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.2515\/therapie\/2013069","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T14:00:10Z","timestamp":1402668010000},"page":"129-141","source":"Crossref","is-referenced-by-count":5,"title":["La doxycycline ou comment faire du neuf avec du vieux ?"],"prefix":"10.1016","volume":"69","author":[{"given":"Nathalie","family":"Shehwaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lyse","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Gueutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Casenave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassane","family":"Izzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2013069_bb0705","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.2515\/therapie\/2013069_bb0710","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0765.1990.tb00923.x","article-title":"Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans","volume":"25","author":"Golub","year":"1990","journal-title":"J Periodontal Res"},{"key":"10.2515\/therapie\/2013069_bb0715","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.bcp.2007.07.004","article-title":"Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease","volume":"75","author":"Raffetto","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.2515\/therapie\/2013069_bb0720","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/10454411910020030201","article-title":"Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs","volume":"2","author":"Golub","year":"1991","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.2515\/therapie\/2013069_bb0725","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1177\/00220345010800111201","article-title":"Experimental gingivitis in women using oral contraceptives","volume":"80","author":"Preshaw","year":"2001","journal-title":"J Dent Res"},{"key":"10.2515\/therapie\/2013069_bb0730","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1034\/j.1600-051X.2001.280810.x","article-title":"Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: post-treatment effects","volume":"28","author":"Caton","year":"2001","journal-title":"J Clin Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0735","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1902\/jop.2002.73.7.762","article-title":"Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis","volume":"73","author":"Novak","year":"2002","journal-title":"J Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0740","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1902\/jop.2000.71.4.521","article-title":"Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis","volume":"71","author":"Caton","year":"2000","journal-title":"J Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0745","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1902\/jop.2000.71.9.1472","article-title":"Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility","volume":"71","author":"Thomas","year":"2000","journal-title":"J Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0750","series-title":"Am Assoc Dent Res.","article-title":"Evaluation of efficacy of administration of sub-antimicrobial-dose doxycycline in the treatment of generalized adult periodontitis in diabetics","author":"Al-Ghazi","year":"2003"},{"key":"10.2515\/therapie\/2013069_bb0755","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1741-2358.2004.00044.x","article-title":"Adjunctive subantimicrobial dose doxycycline in the management of institutionalised geriatric patients with chronic periodontitis","volume":"22","author":"Mohammad","year":"2005","journal-title":"Gerodontology"},{"key":"10.2515\/therapie\/2013069_bb0760","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.139.4.459","article-title":"Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne","volume":"139","author":"Skidmore","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.2515\/therapie\/2013069_bb0765","series-title":"Am Assoc Dent Res.","article-title":"Effect of sub-antimicrobial doxycycline on biomarkers in patients with acute coronary syndromes","author":"Brown","year":"2003"},{"key":"10.2515\/therapie\/2013069_bb0775","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1902\/annals.1998.3.1.51","article-title":"Periodontal disease and diabetes mellitus: a two-way relationship","volume":"3","author":"Grossi","year":"1998","journal-title":"Ann Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0780","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1600-0757.2001.22250103.x","article-title":"Relationship between periodontal disease and systemic health","volume":"25","author":"Garcia","year":"2001","journal-title":"Periodontology 2000"},{"key":"10.2515\/therapie\/2013069_bb0785","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1902\/jop.2004.75.9.1203","article-title":"Gingival crevicular fluid levels of interleukin-1beta and glycemic control in patients with chronic periodontitis and type 2 diabetes","volume":"75","author":"Engebretson","year":"2004","journal-title":"J Periodontol"},{"issue":"Suppl","key":"10.2515\/therapie\/2013069_bb0790","doi-asserted-by":"crossref","first-page":"231S","DOI":"10.1016\/0003-9969(90)90165-7","article-title":"The immediate efficacy of adjunctive doxycycline in treatment of localized juvenile periodontitis","volume":"35","author":"Asikainen","year":"1990","journal-title":"Arch Oral Biol"},{"issue":"Suppl","key":"10.2515\/therapie\/2013069_bb0795","doi-asserted-by":"crossref","first-page":"227S","DOI":"10.1016\/0003-9969(90)90164-6","article-title":"The long-term efficacy of systemic doxycycline medication in the treatment of localized juvenile periodontitis","volume":"35","author":"Sax\u00e9n","year":"1990","journal-title":"Arch Oral Biol"},{"issue":"9","key":"10.2515\/therapie\/2013069_bb0800","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1600-051X.1990.tb01682.x","article-title":"Randomized controlled trial of doxycycline in prevention of recurrent periodontitis in high risk patients: antimicrobial activity and collagenase inhibition","volume":"17","author":"McCulloch","year":"1990","journal-title":"J Clin Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0805","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1034\/j.1600-051x.2001.028002146.x","article-title":"Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis","volume":"28","author":"Golub","year":"2001","journal-title":"J Clin Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0810","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1902\/jop.2002.73.7.762","article-title":"Adjunctive benefits of subantimicrobial dose doxycycline in the management of severe, generalized, chronic periodontitis","volume":"73","author":"Novak","year":"2002","journal-title":"J Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0815","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1034\/j.1600-051x.2002.290204.x","article-title":"Non-surgical periodontal therapy with adjunctive topical Doxycycline: a double-blind randomized controlled multicenter study","volume":"29","author":"Eickholz","year":"2002","journal-title":"J Clin Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0820","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.0303-6979.2004.00576.x","article-title":"Therapy with adjunctive doxycycline local delivery in patients with type 1 diabetes mellitus and periodontitis","volume":"31","author":"Martorelli de Lima","year":"2004","journal-title":"J Clin Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0825","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1902\/jop.2004.75.1.106","article-title":"The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis","volume":"75","author":"Emingil","year":"2004","journal-title":"J Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0830","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1902\/jop.2004.75.3.441","article-title":"Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: a proof of concept trial","volume":"75","author":"Gapski","year":"2004","journal-title":"J Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0835","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1902\/jop.2004.75.8.1068","article-title":"Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planing in chronic periodontitis: a multicenter trial","volume":"75","author":"Preshaw","year":"2004","journal-title":"J Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0840","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/01.STR.0000129334.05181.b6","article-title":"Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model","volume":"35","author":"Lee","year":"2004","journal-title":"Stroke"},{"key":"10.2515\/therapie\/2013069_bb0845","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-051X.2005.00663.x","article-title":"Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis","volume":"32","author":"G\u00fcrkan","year":"2005","journal-title":"J Clin Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0850","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1600-051X.2007.01058.x","article-title":"A randomized-controlled trial of low-dose doxycycline for periodontitis in smokers","volume":"34","author":"Needleman","year":"2007","journal-title":"J Clin Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0855","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1600-051X.2007.01115.x","article-title":"Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women","volume":"34","author":"Payne","year":"2007","journal-title":"J Clin Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0860","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1600-051X.2007.01114.x","article-title":"Efficacy of sub-antimicrobial dose doxycycline in post-menopausal women: clinical outcomes","volume":"34","author":"Reinhardt","year":"2007","journal-title":"J Clin Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0865","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1600-051X.2007.01104.x","article-title":"Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease","volume":"34","author":"T\u00fcter","year":"2007","journal-title":"J Clin Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0870","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1902\/jop.2008.070375","article-title":"Modified-release subantimicrobial dose Doxycycline enhances scaling and root planing in subjects with periodontal disease","volume":"79","author":"Preshaw","year":"2008","journal-title":"J Periodontol"},{"key":"10.2515\/therapie\/2013069_bb0875","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/08959374980120011501","article-title":"Safety and efficacy of sub-antimicrobial-dose doxycycline therapy in patients with adult periodontitis","volume":"12","author":"Ciancio","year":"1998","journal-title":"Adv Dent Res"},{"key":"10.2515\/therapie\/2013069_bb0880","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1600-0765.1983.tb00388.x","article-title":"Minocycline reduces gingival collagenolytic activity during diabetes","volume":"18","author":"Golub","year":"1983","journal-title":"J Periodont Res"},{"key":"10.2515\/therapie\/2013069_bb0885","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0714.2007.00507.x","article-title":"Subantimicrobial dose doxycycline in the treatment of recurrent oral aphthous ulceration: a pilot study","volume":"36","author":"Preshaw","year":"2007","journal-title":"J Oral Pathol Med"},{"key":"10.2515\/therapie\/2013069_bb0890","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2005.04.069","article-title":"A randomized, double-blind, placebo-controlled trial of the combined effect of doxycycline hyclate 20-mg tablets and metronidazole 0.75% topical lotion in the treatment of rosacea","volume":"53","author":"Sanchez","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.2515\/therapie\/2013069_bb0895","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","article-title":"Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea","volume":"56","author":"Del Rosso","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.2515\/therapie\/2013069_bb0900","first-page":"641","article-title":"Combined effect of anti-inflammatory dose doxycycline (40-mg doxycycline, usp monohydrate controlled-release capsules) and metronidazole topical gel 1% in the treatment of rosacea","volume":"6","author":"Fowler","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.2515\/therapie\/2013069_bb0905","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-4632.2008.03445.x","article-title":"Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial","volume":"47","author":"Akhyani","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.2515\/therapie\/2013069_bb0910","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2230.2005.01769.x","article-title":"Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris","volume":"30","author":"Kus","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.2515\/therapie\/2013069_bb0915","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1525-1470.2007.00585.x","article-title":"Progressive macular hypomelanosis in a 16-year old","volume":"25","author":"Perman","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"10.2515\/therapie\/2013069_bb0920","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1067\/mva.2001.117891","article-title":"Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study","volume":"34","author":"Mosorin","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.2515\/therapie\/2013069_bb0925","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1258\/rsmvasc.13.5.290","article-title":"Matrix metalloproteinases in the aneurysm wall of patients treated with low-dose doxycycline","volume":"13","author":"Ding","year":"2005","journal-title":"Vascular"},{"key":"10.2515\/therapie\/2013069_bb0930","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1161\/01.STR.0000038098.04291.F6","article-title":"Prospective, randomized, double-blind trial investigating the effect of doxycycline on matrix metalloproteinase expression within atherosclerotic carotid plaques","volume":"33","author":"Axisa","year":"2002","journal-title":"Stroke"},{"key":"10.2515\/therapie\/2013069_bb0935","first-page":"804","article-title":"Doxycycline in the treatment of rheumatoid arthritis--a pilot study","volume":"48","author":"Sreekanth","year":"2000","journal-title":"J Assoc Physicians India"},{"key":"10.2515\/therapie\/2013069_bb0940","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/1529-0131(200105)44:5<1043::AID-ANR183>3.0.CO;2-C","article-title":"The effects of intravenous doxycycline therapy for rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial","volume":"44","author":"St Clair","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.2515\/therapie\/2013069_bb0945","first-page":"1967","article-title":"Lack of effect of doxycycline on disease activity and joint damage in patients with rheumatoid arthritis. A double blind, placebo controlled trial","volume":"28","author":"van der Laan","year":"2001","journal-title":"J Rheumatol"},{"key":"10.2515\/therapie\/2013069_bb0950","first-page":"41","article-title":"Pilot clinical trial of intravenous doxycycline versus placebo for rheumatoid arthritis","volume":"30","author":"Pillemer","year":"2003","journal-title":"J Rheumatol"},{"key":"10.2515\/therapie\/2013069_bb0955","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/art.21620","article-title":"Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone","volume":"54","author":"O\u2019Dell","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.2515\/therapie\/2013069_bb0960","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-5751-6-11","article-title":"Effectiveness of low-dose doxycycline (LDD) on clinical symptoms of Sj\u00f6gren\u2019s syndrome: a randomized, double-blind, placebo controlled cross-over study","volume":"6","author":"Seitsalo","year":"2007","journal-title":"J Negat Results Biomed"},{"key":"10.2515\/therapie\/2013069_bb0965","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/art.21122","article-title":"Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial","volume":"52","author":"Brandt","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.2515\/therapie\/2013069_bb0970","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.ATV.0000121571.78696.dc","article-title":"Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial","volume":"24","author":"Brown","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.2515\/therapie\/2013069_bb0975","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1532-5415.2004.52109.x","article-title":"A randomized, controlled trial of doxycycline and rifampin for patients with Alzheimer\u2019s disease","volume":"52","author":"Loeb","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.2515\/therapie\/2013069_bb0980","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1371\/journal.ppat.0020092","article-title":"Doxycycline reduces plasma VEGF-C\/sVEGFR-3 and improves pathology in lymphatic filariasis","volume":"2","author":"Debrah","year":"2006","journal-title":"PLoS Pathog"},{"key":"10.2515\/therapie\/2013069_bb0985","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1540-9740.2003.03014.x","article-title":"Subantimicrobial dose doxycycline for acne and rosacea","volume":"2","author":"Bikowski","year":"2003","journal-title":"Skinmed"},{"key":"10.2515\/therapie\/2013069_bb0990","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.107.735274","article-title":"Medical management of small abdominal aortic aneurysms","volume":"117","author":"Baxter","year":"2008","journal-title":"Circulation"},{"key":"10.2515\/therapie\/2013069_bb0995","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mva.2002.125018","article-title":"Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study","volume":"36","author":"Baxter","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.2515\/therapie\/2013069_bb1000","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1161\/CIRCRESAHA.108.174367","article-title":"Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9","volume":"102","author":"Chung","year":"2008","journal-title":"Circ Res"},{"key":"10.2515\/therapie\/2013069_bb1005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jvs.2007.09.016","article-title":"Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome","volume":"47","author":"Xiong","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.2515\/therapie\/2013069_bb1010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-005-2540-3","article-title":"Reduction of myocardial infarct size by doxycycline: a role for plasmin inhibition","volume":"270","author":"Griffin","year":"2005","journal-title":"Mol Cell Biochem"},{"key":"10.2515\/therapie\/2013069_bb1015","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1124\/jpet.107.133975","article-title":"Doxycycline attenuates isoproterenol- and transverse aortic banding-induced cardiac hypertrophy in mice","volume":"324","author":"Errami","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.2515\/therapie\/2013069_bb1020","doi-asserted-by":"crossref","first-page":"H352","DOI":"10.1152\/ajpheart.01101.2007","article-title":"Chronic doxycycline exposure accelerates left ventricular hypertrophy and progression to heart failure in mice after thoracic aorta constriction","volume":"295","author":"Vinet","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.2515\/therapie\/2013069_bb1025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-5-1","article-title":"Suppression of MMP-9 by doxycycline in brain arteriovenous malformations","volume":"5","author":"Hashimoto","year":"2005","journal-title":"BMC Neurol"},{"key":"10.2515\/therapie\/2013069_bb1030","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJM199906103402307","article-title":"Arteriovenous malformations of the brain in adults","volume":"340","author":"The Arteriovenous malformations study group","year":"1999","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie\/2013069_bb1035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3171\/jns.2003.98.1.0003","article-title":"Intention-to-treat analysis of Spetzler-Martin grades IV and V arteriovenous malformations: natural history and treatment paradigm","volume":"98","author":"Han","year":"2003","journal-title":"J Neurosurg"},{"key":"10.2515\/therapie\/2013069_bb1040","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1096\/fj.05-4890fje","article-title":"Transmissibility of mouse AApoAII amyloid fibrils: inactivation by physical and chemical methods","volume":"20","author":"Zhang","year":"2006","journal-title":"FASEB J"},{"key":"10.2515\/therapie\/2013069_bb1045","first-page":"1125","article-title":"The pathogenesis of amyloidosis: understanding general principles","volume":"152","author":"Westermark","year":"1998","journal-title":"Am J Pathol"},{"key":"10.2515\/therapie\/2013069_bb1050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/13506120209114823","article-title":"Amyloid fibril protein nomenclature","volume":"9","author":"Westermark","year":"2002","journal-title":"Amyloid"},{"key":"10.2515\/therapie\/2013069_bb1055","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/385787a0","article-title":"Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis","volume":"385","author":"Booth","year":"1997","journal-title":"Nature"},{"key":"10.2515\/therapie\/2013069_bb1060","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0014-5793(00)02380-2","article-title":"Anti-amyloidogenic activity of tetracyclines: studies in vitro","volume":"487","author":"Forloni","year":"2001","journal-title":"FEBS Lett"},{"key":"10.2515\/therapie\/2013069_bb1065","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1096\/fj.05-4509com","article-title":"Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model","volume":"20","author":"Cardoso","year":"2006","journal-title":"FASEB J"},{"key":"10.2515\/therapie\/2013069_bb1070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001888","article-title":"The efficacy of tetracyclines in peripheral and intracerebral prion infection","volume":"3","author":"De Luigi","year":"2008","journal-title":"PLoS ONE"},{"key":"10.2515\/therapie\/2013069_bb1075","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1006\/jmbi.2000.3840","article-title":"Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro","volume":"300","author":"Tagliavini","year":"2000","journal-title":"J Mol Biol"},{"key":"10.2515\/therapie\/2013069_bb1080","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/77528","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease","volume":"6","author":"Chen","year":"2000","journal-title":"Nat Med"},{"key":"10.2515\/therapie\/2013069_bb1085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/417074a","article-title":"Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice","volume":"417","author":"Zhu","year":"2002","journal-title":"Nature"},{"key":"10.2515\/therapie\/2013069_bb1090","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0272-6386(03)00662-0","article-title":"Doxycycline decreases proteinuria in glomerulonephritis","volume":"42","author":"Ahuja","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.2515\/therapie\/2013069_bb1095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000101726","article-title":"Doxycycline: a pilot study to reduce diabetic proteinuria","volume":"27","author":"Naini","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.2515\/therapie\/2013069_bb1100","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/art.1780351007","article-title":"Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline","volume":"35","author":"Yu","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.2515\/therapie\/2013069_bb1105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-122-2-199501150-00001","article-title":"Minocycline in rheumatoid arthritis-A 48-week, double-blind, placebo-controlled trial","volume":"122","author":"Tilley","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.2515\/therapie\/2013069_bb1110","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1046\/j.1523-1755.2000.00052.x","article-title":"Beta2-microglobulin induces MMP-1 but not TIMP-1 expression in human synovial fibroblasts","volume":"57","author":"Moe","year":"2000","journal-title":"Kidney Int"},{"issue":"9091","key":"10.2515\/therapie\/2013069_bb1115","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(05)64019-6","article-title":"Bartonella-like erythrocyte inclusions in thrombotic thrombocytopenic purpura","volume":"350","author":"Tarantolo","year":"1997","journal-title":"Lancet"},{"key":"10.2515\/therapie\/2013069_bb1120","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.V89.6.1954","article-title":"Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: inhibition by doxycycline and by monoclonal antibody VP-1","volume":"89","author":"Tsai","year":"1997","journal-title":"Blood"},{"key":"10.2515\/therapie\/2013069_bb1125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2257.2004.00594.x","article-title":"Acute thrombotic thrombocytopenic purpura following doxycycline treatment of Chlamydia pneumoniae infection in a patient with dermatomyositis","volume":"26","author":"Knox-Macaulay","year":"2004","journal-title":"Clin Lab Haematol"},{"key":"10.2515\/therapie\/2013069_bb1130","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3201\/eid0803.010249","article-title":"Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient","volume":"8","author":"Safdar","year":"2002","journal-title":"Emerg Infec Dis"},{"key":"10.2515\/therapie\/2013069_bb1135","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0002-9440(10)63512-2","article-title":"A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening","volume":"163","author":"Islam","year":"2003","journal-title":"Am J Pathol"},{"key":"10.2515\/therapie\/2013069_bb1140","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.2001.19.2.584","article-title":"Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer","volume":"19","author":"Rudek","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.2515\/therapie\/2013069_bb1145","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3181\/0705-RM-145","article-title":"Doxycycline influences microcirculation patterns in B16 melanoma","volume":"232","author":"Sun","year":"2007","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.2515\/therapie\/2013069_bb1150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbrc.2003.08.128","article-title":"Restoration of thrombospondin 1 expression in tumor cells harbouring mutant ras oncogene by treatment with low doses of doxycycline","volume":"310","author":"Kalas","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.2515\/therapie\/2013069_bb1155","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bcp.2007.09.012","article-title":"A novel formulation of inhaled doxycycline reduces allergen-induced inflammation, hyperresponsiveness and remodeling by matrix metalloproteinases and cytokines modulation in a mouse model of asthma","volume":"75","author":"Gueders","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.2515\/therapie\/2013069_bb1160","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1056\/NEJMc053410","article-title":"Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs","volume":"354","author":"Moses","year":"2006","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie\/2013069_bb1165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00002018-200022030-00007","article-title":"Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management","volume":"22","author":"Jaspersen","year":"2000","journal-title":"Drug Saf"},{"key":"10.2515\/therapie\/2013069_bb1170","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","article-title":"Safety of doxycycline and minocycline: a systematic review","volume":"27","author":"Smith","year":"2005","journal-title":"Clin Ther"},{"key":"10.2515\/therapie\/2013069_bb1175","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1517\/13543784.9.9.2159","article-title":"Prinomastat, a hydroxamate-based matrix metalloproteinase inhibitor. A novel pharmacological approach for tissue remodelling-related diseases","volume":"9","author":"Scatena","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"issue":"12","key":"10.2515\/therapie\/2013069_bb1180","first-page":"1620","article-title":"Potentiation of warfarin by tetracycline","volume":"37","author":"Westfall","year":"1980","journal-title":"Am J Hosp Pharm"},{"key":"10.2515\/therapie\/2013069_bb1185","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/106002809202600906","article-title":"Enhanced anticoagulant effect of coumarin derivatives induced by doxycycline coadministration","volume":"26","author":"Caraco","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.2515\/therapie\/2013069_bb1190","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archinte.161.9.1231","article-title":"Bleeding associated with doxycycline and warfarin treatment","volume":"161","author":"Baciewicz","year":"2001","journal-title":"Arch Intern Med"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716309684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716309684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T00:05:46Z","timestamp":1597968346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716309684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0040595716309684"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2013069","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}